The mortality rate of non-small cell lung cancer (NSCLC) remains high worldwide. miR-21-5p plays an important part in many cancer types, including NSCLC. However, the effect of miR-21-5p in NSCLC tumorigenesis remains poorly understood. The present study investigated whether miR-21-5p promoted NSCLC cell proliferation in vitro. In order to study the molecular mechanism by which miR-21-5p contributes to NSCLC progression, three bioinformatics algorithms were used to predict the genes which miR-21-5p targeted. TGFBI was identfieid as a putative direct target in NSCLC cells via the luciferase reporter assay. Furthermore, miR-21-5p downregulated TGFBI protein expression by a post-transcriptional mechanism via western blotting and a reverse transcription-quantitative polymerase chain reaction analysis. Finally, TGFBI exhibited opposing effects to those of miR-21-5p on NSCLC cells, suggesting that miR-21-5p may promote cell proliferation by negative regulation of TGFBI. These results suggest miR-21-5p promote the proliferation of NSCLC cells via inhibiting TGFBI expression.
miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells.
miR-21-5p 通过靶向 TGFBI 诱导非小细胞肺癌细胞增殖
阅读:4
作者:Yan Liang, Ma Jinzhu, Wang Yi, Zan Jiawei, Wang Zhen, Zhu Yu, Zhu Yiping, Ling Liefeng, Cao Long, Liu Xin, Li Shu, Xu Lei, Qi Zhilin, Nie Liuwang, Zhang Yao
| 期刊: | Experimental and Therapeutic Medicine | 影响因子: | 2.300 |
| 时间: | 2018 | 起止号: | 2018 Dec;16(6):4655-4663 |
| doi: | 10.3892/etm.2018.6752 | 研究方向: | 细胞生物学 |
| 疾病类型: | 肺癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
